
Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65573 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Atazanavir Ditertbutyl Analog (tert-butyl 2-((2S,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-4-phenylbutyl)-2-(4-(pyridin-2-yl)benzyl)hydrazine-1-carboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H42N4O5Color and Shape:Off-White SolidMolecular weight:562.31552Dichlorothiophene Carboxylic Acid (3,5-dichlorothiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H2Cl2O2SColor and Shape:White Off-White SolidMolecular weight:195.91526Fluconazole
CAS:Anti-infective agents, nesoiFormula:C13H12F2N6OColor and Shape:White Off-White PowderMolecular weight:306.10407Fluvoxamine Maleamide (13-oxo-7-(4-(trifluoromethyl)phenyl)-2,9-dioxa-8,12-diazahexadeca-7,14-dien-16-oic acid)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C19H23F3N2O5Color and Shape:Off-White SolidMolecular weight:416.15591Desimidazoline Sunitinib (5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormula:C14H23N3O2Color and Shape:White Off-White PowderMolecular weight:265.17903Levetiracetam Racemic Mixture (1:1 mixture of levetiracetam S-enantiomer-(2S)-2-(2-oxopyrrolidin-1-yl)butanamide and levetiracetam R-enantiomer (2R)-2-(2-oxopyrrolidin-1-yl)butanamide)
CAS:Lactams, nesoiFormula:C8H14N2O2Color and Shape:White Off-White PowderMolecular weight:170.10553Fesoterodine Fumarate
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C26H37NO3·C4H4O4Color and Shape:White Off-White PowderMolecular weight:527.2883Rivaroxaban N-acyl glycolic acid ((S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C24H21Cl2N3O7S2Color and Shape:Off-White SolidMolecular weight:597.01982-Pyridineethanol (2-(Pyridin-2-yl)ethanol)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C7H9NOColor and Shape:Brown LiquidMolecular weight:123.06841Rivaroxaban phthalimido ethyl ester analog ((S)-1-(1,3-dioxoisoindolin-2-yl)-3-((ethoxycarbonyl)(4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C29H26ClN3O8SColor and Shape:White Off-White SolidMolecular weight:611.11291Duloxetine Related Compound H ((S)-4-{Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino}-4-oxobutanoic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H23NO4SColor and Shape:White Crystalline PowderMolecular weight:397.13478Paroxetine Related Compound E (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C12H14FN·HClColor and Shape:White PowderMolecular weight:191.11103N-Nitroso Metoprolol Solution (1 mL ) (N-(2-hydroxy-3-(4-(2-methoxyethyl)phenoxy)propyl)-N-isopropylnitrous amide)
CAS:Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormula:C15H24N2O4Color and Shape:Colorless LiquidMolecular weight:296.17361Apixaban Related Compound E (Methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFormula:C26H26N4O5Color and Shape:Off-White Light Brown Cream PowderMolecular weight:474.19032Sorafenib Formamide (4-(4-formamidophenoxy)-N-methylpicolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C14H13N3O3Color and Shape:Off-White SolidMolecular weight:271.09569Benzyl Alcohol
CAS:Benzyl alcohol (alpha-hydroxytoluene; phenyl-methanol)Formula:C7H8OColor and Shape:Colorless Clear LiquidMolecular weight:108.14 g/molSodium Starch Glycolate Type A
CAS:Modified starches, nesoiFormula:(C2H4O3)x·(Na)xColor and Shape:White Off-White PowderMolecular weight:515.6862Dabigatran Etexilate Related Compound B (Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate 4-toluenesulfonate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C27H29N7O3·C7H8O3SColor and Shape:White Yellow PowderMolecular weight:671.2526Maltol
CAS:Heterocyclic compounds with oxygen hetero-atom(s) onlyFormula:C6H6O3Color and Shape:White PowderMolecular weight:126.03169

